Calcium Deposits Under the Skin PDF Print E-mail
Thursday, 21 October 2010 10:48
taken from http://www3.dermis.net/dermisroot/en/37958/image.htm
Numerous health effects or conditions are associated with calcinosis or calcium deposits under the skin. According to the Arthritis Foundation, calcinosis is the medical term for calcium deposits that can form under the skin or in the muscles. Calcium deposits in these locations may cause recurrent inflammation or ulcers in the overlying skin. Calcinosis occurs in many medical conditions, along with other symptoms that may decrease a person's quality of life and cause discomfort.

Scleroderma
Scleroderma is a rheumatic disease and connective tissue disease that involves calcium deposits under the skin. According to the National Institute of Arthritis and Musculoskeletal and Skin Diseases or NIAMS, scleroderma is actually a collection or rare and progressive diseases characterized by the hardening and tightening of the skin and connective tissues, or the fibers that support the body and give it a framework. Common signs and symptoms associated with scleroderma include calcium deposits under the skin, swollen fingers and hands, shiny skin and thickened skin. A person with scleroderma also is more likely to develop Raynaud's phenomenon and gastroesophageal reflux disease. Raynaud's phenomenon is an exaggerated response to cold in which a person experiences pain and skin discoloration in the fingers or toes. Gastroesophageal reflux disease or GERD, occurs when acid from the stomach flows up into the esophagus.

Dermatomyositis
Dermatomyositis is an inflammation-related condition that involves calcium deposits under the skin. The National Institute of Neurological Disorders and Stroke or NINDS, states that dermatomyositis is actually one of a group of muscle diseases called inflammatory myopathies that involve long-term muscle inflammation and muscle weakness. According to the NINDS, both children and adults with dermatomyositis can develop calcium deposits, which manifest as hard bumps under the skin or in the muscle. Dermatomyositis-related calcium deposits usually develop 1 to 3 years after the disease begins. Calcinosis is more common in children with dermatomyositis than adults. Other common signs and symptoms associated with dermatomyositis include a violet-colored rash on various parts of the body, progressive muscle weakness, swallowing problems, muscle pain or tenderness, fatigue, fever, weight loss, lung problems and gastrointestinal ulcers.

Lupus
Lupus is an autoimmune condition that involves calcium deposits under the skin. According to the Johns Hopkins Arthritis Center or JHAC, diffuse soft tissue calcification is a rare complication of lupus. Calcinosis tends to manifest in a person who received a diagnosis of lupus at an early age. Most lupus-related calcinosis occurs in the lower extremities, causing both diffuse and nodular densities in the soft tissues of affected areas. Areas of calcium deposition prove more vulnerable to ulceration and infection, reports the JHAC. The cause of lupus-related calcinosis remains unknown. Treatment emphasizes symptom management, including reducing the likelihood of infection. Other common signs and symptoms associated with lupus include a butterfly-shaped rash over the cheeks and bridge of the nose, chest pain, fatigue, fever, general discomfort, hair loss, mouth sores, sensitivity to light and swollen lymph nodes.

Source: Hughes, M (2010), "The Health Effects of Calcium Deposits Under the Skin", Livestrong.com; source article can be viewed here.
 
More articles :

» The Incidence Of Prostate Cancer Higher In Men With Autoimmune Diseases

Men with autoimmune diseases have a higher incidence of (PCa) than those without those diseases, according to study findings presented at the annual meeting.Using the National Inpatient Sample database, researchers obtained data on 189,290 men...

» When Our Antibodies Turn On Us

More than 32 million Americans harbor potentially toxic proteins that can attack body tissues and lead to autoimmune diseases such as Lupus and , according to a new study. This is the first accurate estimate of the frequency of the proteins, called...

» Active Biotech Presents Data regarding the 57-57 Project at EULAR

Active Biotech (NASDAQ OMX Nordic: ACTI) has presented data from an exploratory clinical trial in Systemic Lupus Erythematosus (SLE) patients at the Annual European Congress of Rheumatology EULAR 2011, an international event for specialists in the...

» Top 10 Scleroderma Stories For 2012

For the hundreds of thousands of people around the world, living with Scleroderma can be particularly challenging. As part of the Foundation's ongoing mission, we seek to source and provide useful information, tips, and articles which can help...

» Amira Pharmaceuticals Announces Efficacy of LPA1 Antagonist in a Preclinical Model of Scleroderma

Amira Pharmaceuticals, Inc. announced today that their collaborators, Andrew Tager, M.D. and Flavia V. Castelino, M.D. of Massachusetts General Hospital, Harvard Medical School, will present a preclinical proof-of-concept study which demonstrates...

» Unite Against Scleroderma 2014

For the fourth year running, we will be hosting our annual “Unite Against Scleroderma” Awareness Walk. Scheduled to start from 2:30pm, the Walk would be held on Saturday 3rd May, 2014 and cover one full lap around the Queen’s Park Savannah,...